Differences between enzymes that carry out the synthesis of nucleic acids in eukaryotic and prokaryotic cells allow antibiotics to target these processes in bacterial pathogens.
For example, fluoroquinolones (Figure 6) specifically inhibit bacterial enzymes that unwind the DNA double helix, separating the two strands so that the DNA can make a copy of itself. If this process does not happen, replication is blocked.
Another class of antibiotics – rifamycins – inhibits RNA synthesis by binding to and inhibiting an enzyme called RNA polymerase. This enzyme transfers the instructions carried by genes to the intermediary molecule, mRNA. Interference in this process ultimately stops new proteins being made.
OpenLearn - Understanding antibiotic resistance
Except for third party materials and otherwise, this content is made available under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Licence, full copyright detail can be found in the acknowledgements section. Please see full copyright statement for details.